PREDICT-Meso abstracts accepted for iMig 2023

The international Mesothelioma interest Group (iMig) @imig2023 are hosting their 16th international conference in June in Lille, France.

PREDICT-Meso Network members in Glasgow submitted 6 abstracts and we are delighted to announce that all were accepted-
4 poster presentations and 2 oral presentations.

Oral presentations

Clinical Lecturer in Respiratory Medicine (NHS Greater Glasgow and Clyde, and Univeristy of Glasgow) Dr Geeshath Jayasekera @Geeshath
Abstract Title: Back-translation of human MRI endpoints of Mesothelioma to a Genetically Defined Mouse Model: initial results reveal similar imaging phenotypes to human disease

Visiting Summer student from Universidade Estadual de Campinas (UNICAMP), Brazil, Taylla Theodoro (@TayllaTheodoro)
Abstract Title: Development of an automated machine learning tool for reporting of MRI-Early Contrast Enhancement in Mesothelioma

Poster presentations

PREDICT-Meso Lead Prof Kevin Blyth (@kevingblyth)
Abstract Title: Prediction of Resistance to Chemotherapy using Somatic Copy Number Variation in Mesothelioma; Results of a multi-centre retrospective cohort study

Consultant Radiologist (NHS Greater Glasgow & Clyde) and Meso-ORIGINS radiology lead Dr Gordon Cowell (@GWCowell),
Abstract Title: Extent and sources of discordant therapeutic response classification in malignant pleural mesothelioma by expert readers: A multicentre retrospective cohort study

PREDICT-Meso Clinical Research Fellow, and Meso-ORIGINS clinical study co-ordinator Dr Mark Neilly @MarkNeilly3
Abstract Title: An update regarding the Meso-ORIGINS study (Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, including a nested MRI Sub-Study): part of the PREDICT-Meso Accelerator

Dr Matthew Tate, Macmillan Mesothelioma Clinical Research Fellow (NHS Greater Glasgow and Clyde)
Abstract Title: The Scottish Mesothelioma Network: Impact of a national multidisciplinary team on Overall Survival in Malignant Pleural Mesothelioma